September / October 2022
Features
Deep learning for AMD screening and detection
The potential of automated imaging for finding and monitoring age-related macular degeneration biomarkers.
How telemedicine and AI are changing DR screening
Teleophthalmology and artificial intelligence are bringing diabetic retinopathy screening into the primary-care setting.
The clinical potential of WF-OCT and OCTA
A look at three clinically relevant applications for widefield optical coherence tomography and OCT angiography, along with future directions.
Repair strategies for refractory macular holes
A review of techniques for operating on the small percentage of macular holes that remain problematic after primary surgery.
Departments
Clinical Trial Closeup
Senolytic therapy: ‘Entirely new paradigm’
A look at UBX1325, a small-molecule B-cell inhibitor that targets the proteins senescent cells feed on for survival.
Conference Review
Comparing techniques for RRD, MH
Prime cuts from ASRS also include a quick-response program for CRAO, and trials of agents for GA and mydriasis reversal.
Editor's Page
Imaging Forum
Epitheliopathy after a COVID-19 vaccine
Flashing spots and whitish blots: How OCTA can aid in diagnosis and surveillance.
News
Social Media Specialist
The upsides of social media
A reminder of how we can benefit patients and communities by promoting health literacy and justice.
Surgical Pearl Video
Scleral-fixated IOLs: A modified approach
An optimization of methods to improve efficiency when managing a scleral-fixated intraocular lenses in the operating room.
Uveitis Forum
Managing UGH syndrome
Uveitis-glaucoma-hyphema syndrome, or Ellingson syndrome, requires surgery targeting the intraocular lens to resolve the cause of chafing.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
